Prophylactic cyclo-oxygenase inhibitor drugs for the prevention of morbidity and mortality in preterm infants: a network meta-analysis

Souvik Mitra; Courtney E. Gardner; Abigale MacLellan; Tim Disher; Danielle M. Styranko; Stefan Kuhle; Bradley C. Johnston; Jon Dorling

doi:10.1002/14651858.CD013846

Prophylactic cyclo-oxygenase inhibitor drugs for the prevention of morbidity and mortality in preterm infants: a network meta-analysis

Souvik Mitra, Courtney E. Gardner, Abigale MacLellan, Tim Disher, Danielle M. Styranko, Stefan Kuhle, Bradley C. Johnston, Jon Dorling

Medicine

Producción científica: Contribución a una revista › Artículo › revisión exhaustiva

8 Citas (Scopus)

Resumen

Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To determine the comparative effectiveness and safety of prophylactic cyclo-oxygenase inhibitor (COX-I) drugs (indomethacin, ibuprofen, or acetaminophen) and 'no COX-I prophylaxis' in preterm infants, using a Bayesian network meta-analysis.

Idioma original	English
Número de artículo	CD013846
Publicación	Cochrane Database of Systematic Reviews
Volumen	2021
N.º	1
DOI	https://doi.org/10.1002/14651858.CD013846
Estado	Published - ene. 16 2021

Nota bibliográfica

Funding Information:
We would like to thank Cochrane Neonatal: Colleen Ovelman (Managing Editor), Jane Cracknell (Assistant Managing Editor), Roger Soll (Co-coordinating editor), and Bill McGuire (Co-coordinating Editor), who provided editorial and administrative support. We would also like to thank Robin Parker (WK Kellogg Health Sciences Library, Dalhousie University), as the creator of these searches, and Leah Boulos (Evidence Synthesis Co-ordinator, Maritime SPOR SUPPORT Unit), for her peer review of the MEDLINE search strategy. Menelaos Konstantinidis, Kerry Dwan (Cochrane Methods Support Unit) and Prakeshkumar Shah (Cochrane Neonatal Senior Editor) peer-reviewed and offered feedback for this protocol. The methods section of the protocol is based on a standard template used by Cochrane Neonatal.

Publisher Copyright:
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

ASJC Scopus Subject Areas

Pharmacology (medical)

Acceder al documento

10.1002/14651858.CD013846

Otros archivos y enlaces

Citar esto

Prophylactic cyclo-oxygenase inhibitor drugs for the prevention of morbidity and mortality in preterm infants: a network meta-analysis. / Mitra, Souvik; Gardner, Courtney E.; MacLellan, Abigale et al.
En: Cochrane Database of Systematic Reviews, Vol. 2021, N.º 1, CD013846, 16.01.2021.

Producción científica: Contribución a una revista › Artículo › revisión exhaustiva

@article{dc1d9d6b0fc2450cb6cc9914a9589c57,

title = "Prophylactic cyclo-oxygenase inhibitor drugs for the prevention of morbidity and mortality in preterm infants: a network meta-analysis",

abstract = "Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To determine the comparative effectiveness and safety of prophylactic cyclo-oxygenase inhibitor (COX-I) drugs (indomethacin, ibuprofen, or acetaminophen) and 'no COX-I prophylaxis' in preterm infants, using a Bayesian network meta-analysis.",

author = "Souvik Mitra and Gardner, {Courtney E.} and Abigale MacLellan and Tim Disher and Styranko, {Danielle M.} and Stefan Kuhle and Johnston, {Bradley C.} and Jon Dorling",

note = "Funding Information: We would like to thank Cochrane Neonatal: Colleen Ovelman (Managing Editor), Jane Cracknell (Assistant Managing Editor), Roger Soll (Co-coordinating editor), and Bill McGuire (Co-coordinating Editor), who provided editorial and administrative support. We would also like to thank Robin Parker (WK Kellogg Health Sciences Library, Dalhousie University), as the creator of these searches, and Leah Boulos (Evidence Synthesis Co-ordinator, Maritime SPOR SUPPORT Unit), for her peer review of the MEDLINE search strategy. Menelaos Konstantinidis, Kerry Dwan (Cochrane Methods Support Unit) and Prakeshkumar Shah (Cochrane Neonatal Senior Editor) peer-reviewed and offered feedback for this protocol. The methods section of the protocol is based on a standard template used by Cochrane Neonatal. Publisher Copyright: Copyright {\textcopyright} 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.",

year = "2021",

month = jan,

day = "16",

doi = "10.1002/14651858.CD013846",

language = "English",

volume = "2021",

journal = "Cochrane Database of Systematic Reviews",

issn = "1465-1858",

publisher = "John Wiley and Sons Ltd",

number = "1",

}

TY - JOUR

T1 - Prophylactic cyclo-oxygenase inhibitor drugs for the prevention of morbidity and mortality in preterm infants

T2 - a network meta-analysis

AU - Mitra, Souvik

AU - Gardner, Courtney E.

AU - MacLellan, Abigale

AU - Disher, Tim

AU - Styranko, Danielle M.

AU - Kuhle, Stefan

AU - Johnston, Bradley C.

AU - Dorling, Jon

N1 - Funding Information: We would like to thank Cochrane Neonatal: Colleen Ovelman (Managing Editor), Jane Cracknell (Assistant Managing Editor), Roger Soll (Co-coordinating editor), and Bill McGuire (Co-coordinating Editor), who provided editorial and administrative support. We would also like to thank Robin Parker (WK Kellogg Health Sciences Library, Dalhousie University), as the creator of these searches, and Leah Boulos (Evidence Synthesis Co-ordinator, Maritime SPOR SUPPORT Unit), for her peer review of the MEDLINE search strategy. Menelaos Konstantinidis, Kerry Dwan (Cochrane Methods Support Unit) and Prakeshkumar Shah (Cochrane Neonatal Senior Editor) peer-reviewed and offered feedback for this protocol. The methods section of the protocol is based on a standard template used by Cochrane Neonatal. Publisher Copyright: Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

PY - 2021/1/16

Y1 - 2021/1/16

N2 - Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To determine the comparative effectiveness and safety of prophylactic cyclo-oxygenase inhibitor (COX-I) drugs (indomethacin, ibuprofen, or acetaminophen) and 'no COX-I prophylaxis' in preterm infants, using a Bayesian network meta-analysis.

AB - Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To determine the comparative effectiveness and safety of prophylactic cyclo-oxygenase inhibitor (COX-I) drugs (indomethacin, ibuprofen, or acetaminophen) and 'no COX-I prophylaxis' in preterm infants, using a Bayesian network meta-analysis.

UR - http://www.scopus.com/inward/record.url?scp=85103039511&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85103039511&partnerID=8YFLogxK

U2 - 10.1002/14651858.CD013846

DO - 10.1002/14651858.CD013846

M3 - Article

AN - SCOPUS:85103039511

SN - 1465-1858

VL - 2021

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

IS - 1

M1 - CD013846

ER -

Prophylactic cyclo-oxygenase inhibitor drugs for the prevention of morbidity and mortality in preterm infants: a network meta-analysis

Resumen

Nota bibliográfica

ASJC Scopus Subject Areas

Acceder al documento

Otros archivos y enlaces

Huella

Citar esto